Evidence map›Paper›PMID 15879043›Full record

ReviewPostgraduate medical journal2005

Multiple sclerosis: diagnosis and the management of acute relapses.

S M Leary, B Porter, A J Thompson

Registry-linked trialAbstract readReview
In one paragraph

Review in Postgraduate medical journal, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02490046 (Single Centre Open-label Feasibility Study Evaluating the Use of D-mannose in Multiple Sclerosis), which is not on this map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02490046 phase1unknown statusnot on this mapstarted 2015, after this paper: background citation

Single Centre Open-label Feasibility Study Evaluating the Use of D-mannose in Multiple Sclerosis

TypeinterventionalSponsorUniversity College, LondonRan2015 to 2015Enrolled20ConditionsMultiple Sclerosis, Recurrent Urinary Tract InfectionsArmsD Mannose
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Multiple Sclerosis: Pathogenesis Mechanism and Biomarkers.Central nervous system agents in medicinal chemistry · 2025
    Review
  4. Review
  5. Article
  6. Characterizing the time course of cerebrovascular reactivity in multiple sclerosis.Journal of neuroimaging : official journal of the American Society of Neuroimaging · 2022
    Article
  7. Article
  8. Article
  9. Dietary Inflammatory Index and clinical course of multiple sclerosis.European journal of clinical nutrition · 2019
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Symptomatic management in multiple sclerosis.Annals of Indian Academy of Neurology · 2015
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

S M LearyRehabilitation Group, Institute of Neurology, Queen Square, London, UK.
B Porter
A J Thompson

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple sclerosis is an inflammatory demyelinating disease of the central nervous system that may result in a wide range of neurological symptoms and accumulating disability. Its course is unpredictable resulting in a changing pattern of clinical need. Diagnostic criteria for multiple sclerosis require objective evidence for dissemination in space and time. The diagnostic and management process should follow good practice guidelines with the person at the centre of the process. Appropriate support and information should be available from the time of diagnosis. Continuing education is key in enabling the person to actively participate in their management. In the event of an acute relapse the person should have direct access to the most appropriate local service. Provided medical causes have been excluded, corticosteroid treatment to hasten the recovery from the relapse should be considered. Management of an acute relapse should be comprehensive addressing any medical, functional, or psychosocial sequelae.

Indexed as

AdolescentAdrenal Cortex HormonesAdultAge of OnsetChildCommunicationDiagnosis, DifferentialHumansMiddle AgedMultiple SclerosisPatient ParticipationRecurrenceAdrenal Cortex Hormones

Identifiers

PMID15879043
PMCPMC1743263

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.